Abstract

COVIDE 19 – CONVALESCENT PLASMA AS A OPTIONAL TREATMENT

Komal Satav*, Trusha Shangrapawar and Dr. Ashok Bhosale

Abstract

The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public health crises threatening the earth with the emergence. The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, China in December 2019. No drugs are currently approved for Coronavirus Disease-2019 (COVID-19), although some are tried. This review focuses on convalescent plasma treatment to treat COVID -19. Plasma provided by COVID-19 convalescent patients may provide therapeutic relief because the number COVID-19 cases escalate steeply world-wide. The respiratory diseases including SARS-CoV related pneumonia suggest that convalescent plasma can reduce mortality.

Keywords: Convalescent plasma, COVID-19, Antibody.